1. Market Research
  2. > All Companies
  3. > Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review

Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Boiron SA (Boiron) is a pharmaceutical company. It develops, manufactures and commercializes homeopathic medicines. The company operates through two reportable business segments, namely, Non-proprietary homeopathic medicines, associated with precise therapeutic indications and dosage; and OTC specialties, no specific therapeutic indication or dosage. Its product portfolio comprises Camilia, Euphralia, Arnigel, Oscillococcinum, Sedatif PC, Homeoptic and Stodal. The company has operations in various countries across the world including France, Italy, Spain, Belgium, Switzerland, Germany, the Netherlands, Portugal, Czech Republic, Slovakia, Romania, Hungaria, Poland, Bulgaria, the US, Canada, Tunisia, Morocco, Russia and Brazil. It also manages five production facilities in France and Belgium. Boiron is headquartered in Sainte-Foy-les-Lyon, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Boiron SA - Key Facts 6
Boiron SA - Key Employees 7
Boiron SA - Key Employee Biographies 8
Boiron SA - Major Products and Services 9
Boiron SA - History 10
Boiron SA - Company Statement 12
Boiron SA - Locations And Subsidiaries 13
Head Office 13
Other Locations and Subsidiaries 13
Section 2 - Company Analysis 16
Boiron SA - Business Description 16
Boiron SA - Corporate Strategy 17
Boiron SA - SWOT Analysis 18
SWOT Analysis - Overview 18
Boiron SA - Strengths 18
Strength - Advanced RandD Activities 18
Strength - Operational Network 18
Boiron SA - Weaknesses 19
Weakness - Legal Proceedings 19
Weakness - Decline in Product Sales Affects Revenue 19
Boiron SA - Opportunities 20
Opportunity - Strategic Initiatives 20
Opportunity - Market Potential: Homeopathy 20
Opportunity - Products in Pipeline 20
Boiron SA - Threats 21
Threat - Prejudice Against Homeopathy 21
Threat - Uncertain RandD Outcomes 21
Threat - Growing Parallel Trade 21
Boiron SA - Key Competitors 22
Section 3 - Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 - Company's Lifesciences Financial Deals and Alliances 29
Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 29
Boiron SA, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 30
Boiron SA, Recent Deals Summary 31
Section 5 - Company's Recent Developments 32
Aug 29, 2014: Boiron Reports Revenue Of €261.6m In H1 2014 32
Apr 08, 2014: Boiron Reports Revenue Of €617.7m In 2013 33
Section 6 - Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Boiron SA, Key Facts 6
Boiron SA, Key Employees 7
Boiron SA, Key Employee Biographies 8
Boiron SA, Major Products and Services 9
Boiron SA, History 10
Boiron SA, Subsidiaries 13
Boiron SA, Key Competitors 22
Boiron SA, Ratios based on current share price 23
Boiron SA, Annual Ratios 24
Boiron SA, Interim Ratios 27
Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 29
Boiron SA, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 30
Boiron SA, Recent Deals Summary 31
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Boiron SA, Performance Chart (2010 - 2014) 26
Boiron SA, Ratio Charts 28
Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 29
Boiron SA, Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 30

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.